CN119654556A - 检测ceacam1的方法 - Google Patents

检测ceacam1的方法 Download PDF

Info

Publication number
CN119654556A
CN119654556A CN202380058220.7A CN202380058220A CN119654556A CN 119654556 A CN119654556 A CN 119654556A CN 202380058220 A CN202380058220 A CN 202380058220A CN 119654556 A CN119654556 A CN 119654556A
Authority
CN
China
Prior art keywords
ceacam1
antibody
cancer
recognizing
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380058220.7A
Other languages
English (en)
Chinese (zh)
Inventor
新井修
八木慎太郎
青柳克己
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Life Science Institute Inc
Original Assignee
Advanced Life Science Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Life Science Institute Inc filed Critical Advanced Life Science Institute Inc
Publication of CN119654556A publication Critical patent/CN119654556A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2470/00—Immunochemical assays or immunoassays characterised by the reaction format or reaction type
    • G01N2470/04—Sandwich assay format

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
CN202380058220.7A 2022-08-08 2023-08-07 检测ceacam1的方法 Pending CN119654556A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022126644 2022-08-08
JP2022-126644 2022-08-08
PCT/JP2023/028802 WO2024034580A1 (ja) 2022-08-08 2023-08-07 Ｃｅａｃａｍ１を検出する方法

Publications (1)

Publication Number Publication Date
CN119654556A true CN119654556A (zh) 2025-03-18

Family

ID=89851807

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380058220.7A Pending CN119654556A (zh) 2022-08-08 2023-08-07 检测ceacam1的方法

Country Status (4)

Country Link
US (1) US20260194525A1 (cg-RX-API-DMAC7.html)
JP (1) JPWO2024034580A1 (cg-RX-API-DMAC7.html)
CN (1) CN119654556A (cg-RX-API-DMAC7.html)
WO (1) WO2024034580A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN122193579A (zh) * 2026-05-15 2026-06-12 杭州市第一人民医院(西湖大学附属杭州市第一人民医院) 一种用于胰腺癌筛查和诊断的联合检测血清标志物、试剂盒及检测方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900684A (en) * 1987-06-01 1990-02-13 Immunomedics, Inc. CEA immunoassay free of human anti-mouse antibody false positives
EP0711415B1 (de) * 1993-07-28 1998-07-22 Boehringer Mannheim Gmbh Immunoassay zum nachweis von kollagen typ i oder kollagenfragmenten davon
JP3269765B2 (ja) * 1995-12-14 2002-04-02 富士写真フイルム株式会社 ヘモグロビン誘導体の免疫学的測定方法及びその方法に用いる処理試薬
JPH09178752A (ja) * 1995-12-26 1997-07-11 Lion Corp 微生物の検出方法及び検出用検査セット
JP3740898B2 (ja) * 1998-07-31 2006-02-01 三菱化学株式会社 生理活性成分の測定法
CA2768725A1 (en) * 2009-07-21 2011-01-27 Tel Hashomer Medical Research Infrastructure And Services Ltd. A method of diagnosing cancer
JP5852329B2 (ja) * 2011-05-31 2016-02-03 積水メディカル株式会社 ＨｂＡ１ｃの免疫学的測定方法
WO2013054320A1 (en) * 2011-10-11 2013-04-18 Tel Hashomer Medical Research Infrastructure And Services Ltd. Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
CN103060361A (zh) * 2013-01-25 2013-04-24 昆明医科大学第一附属医院 CEACAMl蛋白磁粒的制备方法和应用
CA3029926C (en) * 2016-07-25 2023-01-03 Shizuoka Prefecture Diagnostic biomarker for extrahepatic bile duct cancer, intrahepatic bile duct cancer or gallbladder cancer
JP2019196917A (ja) * 2018-05-07 2019-11-14 東洋紡株式会社 測定試料希釈液

Also Published As

Publication number Publication date
US20260194525A1 (en) 2026-07-09
JPWO2024034580A1 (cg-RX-API-DMAC7.html) 2024-02-15
WO2024034580A1 (ja) 2024-02-15

Similar Documents

Publication Publication Date Title
CN105980407B (zh) 单克隆抗tk1抗体
CN103483450B (zh) 抗人cxcl1单克隆抗体或其片段
CN111566214B (zh) 抗人IgG4单克隆抗体及利用该抗体的人IgG4测定试剂
JP2023527937A (ja) 抗ｃｌｄｎ１８．２抗体及びその診断用途
CN108473552A (zh) 检测外泌体蛋白eif3a的特异性自身抗体的抗原性组合物和使用其诊断肝癌的方法
CN101160526B (zh) 针对胃泌素释放肽前体的抗体及其应用
CN114369160B (zh) 结合抗繆勒氏管激素amhn二聚体蛋白的高亲和力兔单抗
CN110114676B (zh) 肾素浓度的免疫学测定方法
CN113727995A (zh) 检测癌的方法和检测试剂
WO2024034580A1 (ja) Ｃｅａｃａｍ１を検出する方法
EP4189396A1 (en) Improved epitope for detecting and/or quantifying autoantibodies against alpha-fetoprotein
WO2017155355A1 (ko) Aimp2-dx2 단백질에 특이적으로 결합하는 항체
US20220235139A1 (en) Anti-csf-ir antibody
JPH10226700A (ja) Ｍｉａの検出のためのイムノアッセイ
CN107056931B (zh) 一种抗原肽和nod1抗体及应用、制备方法和试剂盒
CN105474016B (zh) Augurin免疫试验
JP7845752B2 (ja) Ｉ型コラーゲンｃ末端テロペプチドの免疫学的分析方法、分析キット、及びモノクローナル抗体
CN103261221B (zh) 肌动蛋白丝切蛋白1蛋白质的免疫学测定方法
WO2023223796A1 (ja) コリバクチン産生大腸菌結合性抗体
JPWO2018079393A1 (ja) ジスルフィド型ｈｍｇｂ１特異的抗体、ジスルフィド型ｈｍｇｂ１の測定方法および測定用キット、ならびに、還元型ｈｍｇｂ１、ジスルフィド型ｈｍｇｂ１、トロンビン分解ｈｍｇｂ１等の全てのｈｍｇｂ１を定量することが可能な測定方法および測定用キット
WO2025100378A1 (ja) Ｇｐｃ３の測定方法及びそのためのキット
WO2025182761A1 (ja) Ｇｆａｐの検出方法、アルツハイマー病の診断を補助する方法、及びそれらに用いるキット
KR20230159454A (ko) 악성 췌장 낭포성 종양의 판정 보조 방법 및 판정 보조용 키트
CN105542009A (zh) 一种针对前列腺特异性膜抗原的单域重链抗体
JPH10512369A (ja) 癌診断薬としてのａ蛋白質

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination